Cargando…
Recommendations from national regulatory agencies for ongoing cancer trials during the COVID-19 pandemic
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier Ltd.
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7252196/ https://www.ncbi.nlm.nih.gov/pubmed/32277907 http://dx.doi.org/10.1016/S1470-2045(20)30226-6 |
| _version_ | 1783539112592015360 |
|---|---|
| author | de Paula, Bruno H R Araújo, Indiara Bandeira, Lívia Barreto, Nathália M P B Doherty, Gary J |
| author_facet | de Paula, Bruno H R Araújo, Indiara Bandeira, Lívia Barreto, Nathália M P B Doherty, Gary J |
| author_sort | de Paula, Bruno H R |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-7252196 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2020 |
| publisher | Elsevier Ltd. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-72521962020-05-28 Recommendations from national regulatory agencies for ongoing cancer trials during the COVID-19 pandemic de Paula, Bruno H R Araújo, Indiara Bandeira, Lívia Barreto, Nathália M P B Doherty, Gary J Lancet Oncol Comment Elsevier Ltd. 2020-05 2020-04-08 /pmc/articles/PMC7252196/ /pubmed/32277907 http://dx.doi.org/10.1016/S1470-2045(20)30226-6 Text en © 2020 Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Comment de Paula, Bruno H R Araújo, Indiara Bandeira, Lívia Barreto, Nathália M P B Doherty, Gary J Recommendations from national regulatory agencies for ongoing cancer trials during the COVID-19 pandemic |
| title | Recommendations from national regulatory agencies for ongoing cancer trials during the COVID-19 pandemic |
| title_full | Recommendations from national regulatory agencies for ongoing cancer trials during the COVID-19 pandemic |
| title_fullStr | Recommendations from national regulatory agencies for ongoing cancer trials during the COVID-19 pandemic |
| title_full_unstemmed | Recommendations from national regulatory agencies for ongoing cancer trials during the COVID-19 pandemic |
| title_short | Recommendations from national regulatory agencies for ongoing cancer trials during the COVID-19 pandemic |
| title_sort | recommendations from national regulatory agencies for ongoing cancer trials during the covid-19 pandemic |
| topic | Comment |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7252196/ https://www.ncbi.nlm.nih.gov/pubmed/32277907 http://dx.doi.org/10.1016/S1470-2045(20)30226-6 |
| work_keys_str_mv | AT depaulabrunohr recommendationsfromnationalregulatoryagenciesforongoingcancertrialsduringthecovid19pandemic AT araujoindiara recommendationsfromnationalregulatoryagenciesforongoingcancertrialsduringthecovid19pandemic AT bandeiralivia recommendationsfromnationalregulatoryagenciesforongoingcancertrialsduringthecovid19pandemic AT barretonathaliampb recommendationsfromnationalregulatoryagenciesforongoingcancertrialsduringthecovid19pandemic AT dohertygaryj recommendationsfromnationalregulatoryagenciesforongoingcancertrialsduringthecovid19pandemic |